Status:
COMPLETED
Evolution of the Quality of Life and Experience of Young Women With Utero-vaginal Aplasia (MRKHPSY)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Foundation for Rare Diseases
Necker Imagine Foundation
Conditions:
Mrkh Syndrome
Eligibility:
FEMALE
18+ years
Brief Summary
This study aims to evaluate the global evolution of the quality of life on patients diagnosed with MRKH syndrome (Mayer-Rokitansky-Kuster-Hauser), 8 to 10 years after the first research.
Detailed Description
Between 2012 and 2015, the French national reference center for rare gynecological pathologies (PGR) has conducted a study with 2 axis: a medical and a psychological section (clinical trial number NCT...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient aged of 18 years old or older
- Patient who participated in the initial T1 psychological component of the previous study (MRKH protocol)
- Exclusion Criteria
- \- Refusal to participate in the study
Exclusion
Key Trial Info
Start Date :
October 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 27 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05415540
Start Date
October 4 2022
End Date
February 27 2024
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Necker Children's Hospital
Paris, France, 75015